Learn More
Enramycin, G-Biosciences

Description
Enramycin is a polypeptide antibiotic that displays strong activity against gram positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). It is produced by the fungus Streptomyces fungicidus as Enramycin A (EA) and Enramycin B (EB), with this product containing an approximate 70:30 ratio of EA to EB. Enramycin has been effective against antibiotic resistant bacteria by inhibiting peptidoglycan synthesis for bacterial cell walls
Enramycin has been proposed to halt peptidoglycan synthesis by inhibiting transferase enzyme MurG or by inhibiting transglycosylase activity. Both inhibitory pathways entail enramycin binding to peptidoglycan precursors in a cell wall synthesis pathway. Some studies have shown that enramycin binds the precursor Lipid I and inhibits MurG. Enramycin has also been shown to bind the Lipid II and prevent transglycosylation of the precursor by tranglycosylases.
Specifications
Specifications
| Boiling Point | >231°C |
| Quantity | 10 mg |
| Percent Purity | >95% |
| Grade | Laboratory |
| Physical Form | Powder |
| Product Line | Gibco |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.